These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy]. Ibáñez Sendín MD Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375 [TBL] [Abstract][Full Text] [Related]
6. [The value of immunotherapy in treatment of IgE-induced allergic diseases]. Müller UR Ther Umsch; 1994 Jan; 51(1):67-76. PubMed ID: 7511841 [TBL] [Abstract][Full Text] [Related]
7. [Role of desensitization in the treatment of respiratory allergies]. Vervloet D; Romanet S; Magnan A Rev Mal Respir; 2000 Feb; 17(1 Pt 2):287-92. PubMed ID: 10902142 [TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937 [TBL] [Abstract][Full Text] [Related]
10. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. Frew AJ; Powell RJ; Corrigan CJ; Durham SR; J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133 [TBL] [Abstract][Full Text] [Related]
12. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Dahl R; Stender A; Rak S Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194 [TBL] [Abstract][Full Text] [Related]
13. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Halken S Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698 [TBL] [Abstract][Full Text] [Related]
16. [New administration routes for immunotherapy]. Martorell Aragonés A Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377 [TBL] [Abstract][Full Text] [Related]
17. Impact of allergen immunotherapy in allergic asthma. Zhang W; Lin C; Sampath V; Nadeau K Immunotherapy; 2018 Jun; 10(7):579-593. PubMed ID: 29569506 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of injection-related and local immunotherapy]. Kuna P Pol Merkur Lekarski; 2003 Jun; 14(84):695-9. PubMed ID: 14524308 [TBL] [Abstract][Full Text] [Related]
19. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma. Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305 [TBL] [Abstract][Full Text] [Related]
20. Novel routes for allergen immunotherapy: safety, efficacy and mode of action. Moingeon P; Mascarell L Immunotherapy; 2012 Feb; 4(2):201-12. PubMed ID: 22339462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]